Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Cash from Financing Activities (2024 - 2025)

Hinge Health (HNGE) has disclosed Cash from Financing Activities for 2 consecutive years, with -$79.5 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 3306.64% to -$79.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$81.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at -$150.5 million for FY2025, 6733.24% down from the prior year.
  • Cash from Financing Activities hit -$79.5 million in Q4 2025 for Hinge Health, down from $531000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $531000.0 in Q3 2025 to a low of -$79.5 million in Q4 2025.